Projects and Grants per year
Personal profile
Education/Academic qualification
Post Doctoral Fellow, Baylor University
1999
Residency, University Of Kentucky
1998
Internship, East Tennessee State University
1994
Doctor of Medicine, East Tennessee State University
1993
Bachelor of Science, East Tennessee State University
1988
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Kimberly Absher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Investigating the Role of HDL-Associated Serum Amyloid A in Sepsis-induced Acute Lung Injury and Mortality
Shridas, P. (PI), Absher, K. (CoI), Brainson, C. (CoI), Gordon, S. (CoI), Kryscio, R. (CoI), Starr, M. (CoI), Sturgill, J. (CoI) & Waters, C. (Former CoI)
National Heart Lung and Blood Institute
1/1/25 → 11/30/28
Project: Research project
-
Methionine Metabolism and Lung Cancer Lineage Fate
Brainson, C. (PI), Absher, K. (CoI), Liu, J. (CoI) & Wang, C. (CoI)
7/1/19 → 12/31/23
Project: Research project
-
Cancer Prevention and Control: An Integrated, Population-Based Community and Cancer Center Program, A Focus on Early Detection, Molecular Epidemiology and State-of-the-Art Treatment for Lung, Esophageal, Liver and Pancreatic Cancer
Arnold, S. M. (PI), Absher, K. (CoI), Baron, A. (CoI), Holzhauer, M. (CoI), Hopenhayn, C. (CoI), Koch, A. (CoI), Lele, S. (CoI), Mannino, D. (CoI), Mullett, T. (CoI), Nickl, N. (CoI), Shelton, B. (CoI), Tucker, T. (CoI) & Cohen, A. (Former PI)
Center for Disease Control and Prevention
9/1/04 → 1/30/07
Project: Research project
-
Low-Dose Fractionated Radiation Plus Docetaxel and Cisplatin as Induction Therapy
Ahmed, M. (PI), Absher, K. (CoI), Arnold, S. M. (CoI), Kryscio, R. (CoI), Mullett, T. (CoI) & Yoneda, J. (CoI)
2/1/03 → 1/31/05
Project: Research project
-
Low-Dose Fractionated Radiation Plus Docetaxel and Cisplatin as Induction Therapy
Arnold, S. M. (PI), Ahmed, M. (CoI), Absher, K. (CoI), Kryscio, R. (CoI), Mullett, T. (CoI) & Yoneda, J. (CoI)
2/1/03 → 1/31/10
Project: Research project
Research output
- 14 Article
-
Pulmonary pleomorphic carcinoma: current understanding illustrated through a case
Dolkar, T., Absher, K. & Hao, Z., Aug 30 2024, In: BMJ Case Reports. 17, 8, e261076.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis
Conroy, L. R., Clarke, H. A., Allison, D. B., Valenca, S. S., Sun, Q., Hawkinson, T. R., Young, L. E. A., Ferreira, J. E., Hammonds, A. V., Dunne, J. B., McDonald, R. J., Absher, K. J., Dong, B. E., Bruntz, R. C., Markussen, K. H., Juras, J. A., Alilain, W. J., Liu, J., Gentry, M. S. & Angel, P. M. & 2 others, , Dec 2023, In: Nature Communications. 14, 1, 2759.Research output: Contribution to journal › Article › peer-review
Open Access63 Scopus citations -
Spatiotemporal Analysis of Lung Cancer Histological Types in Kentucky, 1995–2014
Christian, W. J., Vanderford, N. L., McDowell, J., Huang, B., Durbin, E. B., Absher, K. J., Walker, C. J. & Arnold, S. M., Jan 1 2019, In: Cancer Control. 26, 1Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
Huang, T., Engelmann, B. J., Morgan, R. M., Absher, K. J., Kolesar, J. M. & Villano, J. L., May 2018, In: Cancer Chemotherapy and Pharmacology. 81, 5, p. 965-968 4 p.Research output: Contribution to journal › Article › peer-review
-
EML4–ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
Huang, T., Engelmann, B. J., Morgan, R. M., Absher, K. J., Kolesar, J. M. & Villano, J. L., May 1 2018, In: Cancer Chemotherapy and Pharmacology. 81, 5, p. 965-968 4 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations